VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 624 filers reported holding VANECK VECTORS ETF TR in Q2 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $22,228 | +5.5% | 826 | +18.0% | 0.00% | 0.0% |
Q2 2023 | $21,077 | -10.1% | 700 | -3.4% | 0.00% | -33.3% |
Q1 2023 | $23,454 | +16.9% | 725 | +3.6% | 0.00% | +50.0% |
Q4 2022 | $20,062 | -8.8% | 700 | -22.2% | 0.00% | -33.3% |
Q3 2022 | $22,000 | -15.4% | 900 | -6.3% | 0.00% | 0.0% |
Q2 2022 | $26,000 | -39.5% | 961 | -14.9% | 0.00% | -40.0% |
Q1 2022 | $43,000 | +38.7% | 1,129 | +17.5% | 0.01% | +66.7% |
Q4 2021 | $31,000 | +24.0% | 961 | +11.6% | 0.00% | 0.0% |
Q3 2021 | $25,000 | -56.1% | 861 | -50.0% | 0.00% | -25.0% |
Q2 2021 | $57,000 | +103.6% | 1,722 | +100.0% | 0.00% | 0.0% |
Q1 2021 | $28,000 | -12.5% | 861 | 0.0% | 0.00% | -33.3% |
Q2 2020 | $32,000 | +60.0% | 861 | 0.0% | 0.01% | +50.0% |
Q1 2020 | $20,000 | -20.0% | 861 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $25,000 | -43.2% | 861 | -48.0% | 0.00% | -50.0% |
Q3 2019 | $44,000 | +25.7% | 1,655 | +22.1% | 0.01% | +33.3% |
Q2 2019 | $35,000 | – | 1,355 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |